Back to results
US 12,521,430 B2Granted
Methods of generating broadly protective vaccine compositions comprising neuraminidase
AssigneesSanofi Pasteur Limited, Vir Vzw, Universiteit Gent
InventorsTod Strugnell, Eliud Oloo, Raymond Oomen, Thorsten Vogel, Xavier Saelens, Emma Job
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a cluster-based consensus approach for generating recombinant neuraminidase (NA) polypeptides. The disclosure further relates to influenza vaccine compositions comprising the recombinant NA polypeptides.
Claims9
A method for producing a recombinant influenza neuraminidase (NA) polypeptide comprising consensus amino acids, wherein the method comprises:
- a. selecting more than one influenza NA polypeptide sequence and aligning the sequences;
- b. calculating pairwise similarity/dissimilarity matrices;
- c. identifying and creating clusters of similar sequences from the pairwise similarity/dissimilarity matrices;
- d. within each cluster, determining whether there is a consensus amino acid for each position in the sequence alignment using a pairwise alignment method, wherein if the frequency of the amino acid at a given position is 50% or greater, that amino acid is designated a consensus amino acid, and if the frequency of the amino acid at a given position is less than 50%, that amino acid is designated as a variable amino acid;
- e. generating a first sequence comprising consensus amino acids and variable amino acids for each cluster;
- f. within the first sequence generated in step (e), determining a consensus amino acid for each variable amino acid position, by:
- i. generating a set of test sequences based on the first sequence, wherein test amino acids are placed at the variable amino acid positions;
- ii. performing molecular modeling for each of the test sequences;
- and
- iii. determining a consensus amino acid for each variable amino acid position by selecting amino acid(s) that result in a polypeptide having a negative total energy value and generating a candidate sequence comprising the selected consensus amino acid(s);
- g. producing the recombinant influenza NA polypeptide comprising the candidate sequence, wherein the candidate sequence differs from the more than one influenza NA polypeptide sequences of step (a);
- and
- h. isolating the produced recombinant influenza NA polypeptide.
10 more elements
Dependencies are inferred from the claim text.